Mapping Disease Transitions from Premalignant, Asymptomatic to Advanced Myeloma through Integrative Epigenomic and Transcriptional Analyses
Aleksandra K. Kurowska, Azari Bantan, Raghad Shuwaikan, Nahia Gómez-Echarte, Itziar Cenzano, Paula Aguirre‐Ruiz, Estíbaliz Miranda, Leire Gárate, Amaia Vilas‐Zornoza, Patxi San-Martin, Marta Larráyoz, Beñat Ariceta, Ane Amundarain, Daniel Soto Ortiz, Markos Tsitsianopoulos, , David Gómez-Cabrero
This study maps epigenetic and transcriptional changes in myeloma progression from precursor to advanced stages, identifying key transcription factors involved in disease development.
Blood · Nov 5, 2024Peer-reviewedCancer Biology